EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones



Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones



Journal of Pharmaceutical and Biomedical Analysis 41(3): 957-965



Soy food or food supplements based on soy containing isoflavones (Isos) are increasingly available in Western countries. However, the variability of Isos levels in urine and plasma in humans during chronic ingestion is poorly documented. Nevertheless, this is the way these compounds will most probably be used in the future, especially if the soy-based supplements market goes on increasing. Here, glycosilated Isos in an enriched extract of Prevastein equal to 100 mg of equivalent Isos aglycone was given daily to 27 post-menopausal women for 30 days and to 12 post-menopausal women for 60 days. Volunteers were given Prevastein in a cereal bar (25 mg Isos) and in a yoghurt (25 mg Isos) both at breakfast and dinner. Plasma samples were collected after overnight fasting. Urine samples were aliquots of a 24 h collection checked on volume and creatinine excretion levels. Genistein, daidzein and equol were measured at day 0 and every 15 days afterwards, using original specific ELISAs. Constant levels were reached from the 15th day. About 59.2% of the volunteers were significant equol producers in the first experiment and 58.3% in the second. A large variability in plasma and urine levels was observed among post-menopausal women consuming 100 mg Isos per day, although remaining relatively stable in each individual subject. This could partly account for the controversial effects of Isos recorded so far in clinical studies. So Isos plasma levels would have to be assayed during chronic exposures, and could help to better understand the large variability of the effects classically observed in clinical studies. ELISA techniques could be easily exported to analytical laboratories to help physicians and nutritionists with their prescriptions.

(PDF emailed within 0-6 h: $19.90)

Accession: 004510061

Download citation: RISBibTeXText

PMID: 16513315

DOI: 10.1016/j.jpba.2006.01.051



Related references

Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women. Proceedings of the Nutrition Society 65(1): 106-115, 2006

Correlations between blood isoflavones and blood lipids in hypercholesterolemic men and post-menopausal women fed soy protein with differing levels of isoflavones. FASEB Journal 13(4 PART 1): A556, March 12, 1999

Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Human Reproduction Update 16(1): 110-1; Author Reply 111-2, 2010

Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Human Reproduction Update 15(4): 423-440, 2009

Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women. Journal of Endocrinological Investigation 32(2): 150-155, 2009

Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vascular Medicine 9(1): 26-30, 2004

The isoflavones and the lipid profile in post-menopausal women Randomized clinical trial. Revista Brasileira De Medicina: 9, 288-291, 2008

Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women. Gynecological Endocrinology 29(3): 209-212, 2013

Food matrix and isoflavones bioavailability in early post menopausal women: a European clinical study. Clinical Interventions in Aging 3(4): 711-718, 2009

Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. Journal of Clinical Endocrinology and Metabolism 84(3): 895-898, 1999

Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Maturitas 54(3): 270-276, 2006

Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 17(12): 3392-3398, 1998

Effect of a mixture of calcium, vitamin D, inulin and soy isoflavones on bone metabolism in post-menopausal women: a retrospective analysis. Aging Clinical and Experimental Research 25(6): 611-617, 2014

The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152(1): 143-147, September, 2000

Plasma and urine diketopiperazine concentrations in normal adults ingesting large quantities of aspartame. Food & Chemical Toxicology 25(7): 499-504, 1987